EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $591,741 | -1.5% | 30,965 | 0.0% | 0.65% | -11.7% |
Q1 2023 | $601,031 | -42.8% | 30,965 | -52.7% | 0.74% | -28.2% |
Q4 2022 | $1,050,604 | +149.5% | 65,499 | +157.1% | 1.03% | +145.1% |
Q3 2022 | $421,000 | -58.6% | 25,480 | -47.8% | 0.42% | -55.4% |
Q2 2022 | $1,017,000 | +78.1% | 48,837 | +93.9% | 0.94% | +126.5% |
Q1 2022 | $571,000 | +4.6% | 25,182 | +9.6% | 0.42% | +128.0% |
Q2 2020 | $546,000 | -76.5% | 22,979 | -82.9% | 0.18% | -81.3% |
Q1 2020 | $2,321,000 | +28.8% | 134,756 | +31.8% | 0.98% | +53.8% |
Q4 2019 | $1,802,000 | -2.1% | 102,270 | 0.0% | 0.63% | -9.6% |
Q3 2019 | $1,840,000 | +97.8% | 102,270 | +135.8% | 0.70% | +105.6% |
Q2 2019 | $930,000 | +10.3% | 43,378 | 0.0% | 0.34% | -8.6% |
Q1 2019 | $843,000 | 0.0% | 43,378 | 0.0% | 0.37% | +3.6% |
Q4 2018 | $843,000 | +10.2% | 43,378 | 0.0% | 0.36% | +37.4% |
Q3 2018 | $765,000 | -16.8% | 43,378 | 0.0% | 0.26% | -22.9% |
Q2 2018 | $920,000 | -4.3% | 43,378 | 0.0% | 0.34% | -13.9% |
Q1 2018 | $961,000 | – | 43,378 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
AJO, LP | 7,636,882 | $134,561,000 | 0.80% |